Wednesday, February 10, 2010, 3:11pm SGT - The Singapore stock market closes in 1 hour and 49 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

Given Imaging Ltd. (GIVN)

At 5:00AM SGT: 15.13 USD  Up 0.08 (0.53%)  
 MORE ON GIVN 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Given Imaging Ltd. (NGM:GIVN) Delayed quote dataEdit
After Hours: 15.17 Up 0.04 (0.26%) as of 5:52am SGT on 02/10/10
Last Trade:15.13 USD
Trade Time:5:00AM SGT
Change:Up 0.08 (0.53%)
Prev Close:15.05
Open:15.02
Bid:14.73 x 200
Ask:15.53 x 200
1y Target Est:20.04
Day's Range:14.87 - 15.22
52wk Range:6.76 - 18.37
Volume:71,466
Avg Vol (3m):166,056
Market Cap:443.22M
P/E (ttm):66.36
EPS (ttm):0.23
Div & Yield:0.54 (3.59%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add GIVN to Portfolio   Download Data

 HEADLINES 
Given Imaging to Host Fourth Quarter 2009 Financial Results Conference Calls
Marketwire (Mon, Feb 1)
Given Imaging to Present at the 28th Annual J.P. Morgan Healthcare Conference
Marketwire (Wed, Jan 6)
ObamaCare Using PBMs As A Solution To High Health Care Costs: Which Stocks To Benefit?
Wall Street Transcript (Thu, Dec 17)
Given Imaging Enters Oversold Territory
Zacks.com (Wed, Dec 16)
The 200-Day Moving Average & 3 PowerRatings Stocks for Traders
TradingMarkets.com (Wed, Dec 16)
Three Studies Find PillCam(R) SB Enables Earlier Diagnosis and Treatment of GI Diseases Including Crohn's
Marketwire (Wed, Nov 25)
Given Imaging Announces RAPID(R) pH Software for Bravo(R) pH Monitoring System
Marketwire (Tue, Nov 24)
New Studies Show PillCam(R) SB to Be Clinically Valuable in Classifying and Managing Pediatric GI Symptoms
Marketwire (Tue, Nov 24)
Given Imaging Meeting to Discuss New Features of PillCamĀ® COLON 2 and Review Results from Israeli Feasibility Trial Call scheduled for 9:00 am ET today
CCBN (Mon, Nov 23)
Given Imaging Launches Next-Generation PillCam(R) COLON 2 at GASTRO 2009 Conference
Marketwire (Mon, Nov 23)
Israel Stocks: Israel stocks off; Africa Times-building deal seen
at MarketWatch (Thu, Nov 19)
More Headlines for GIVN...

 ANALYST 
EPS Est (next year) (Dec-09) :0.43
EPS Est (in 2 years) (Dec-10) :0.50
Avg Rec (current)*:1.8
PEG Ratio:1.69
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Given Imaging Ltd. develops, manufactures, and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices